Literature DB >> 19557205

Real-life asthma care in Canada.

R A McIvor1, J Sampalis.   

Abstract

Mesh：

Year:  2009        PMID： 19557205      PMCID： PMC3486713          DOI： 10.1155/2009/328963

Source DB:  PubMed          Journal:  Can Respir J        ISSN： 1198-2241            Impact factor:   2.409


× No keyword cloud information.
  7 in total

1.  The coming of age of asthma guidelines.

Authors:  R Andrew McIvor; Kenneth R Chapman
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

2.  Asthma control in Canada: no improvement since we last looked in 1999.

Authors:  R Andrew McIvor; Louis-Philippe Boulet; J Mark FitzGerald; Sabrina Zimmerman; Kenneth R Chapman
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275

3.  Suboptimal asthma control: prevalence, detection and consequences in general practice.

Authors:  K R Chapman; L P Boulet; R M Rea; E Franssen
Journal:  Eur Respir J       Date:  2007-10-24       Impact factor: 16.671

4.  The Brussels Declaration: the need for change in asthma management.

Authors:  S Holgate; H Bisgaard; L Bjermer; T Haahtela; J Haughney; R Horne; A McIvor; S Palkonen; D B Price; M Thomas; E Valovirta; U Wahn
Journal:  Eur Respir J       Date:  2008-12       Impact factor: 16.671

5.  Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial.

Authors:  R Andrew McIvor; Alan Kaplan; Caroline Koch; John S Sampalis
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409

6.  Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial).

Authors:  Paul K Keith; Caroline Koch; Michel Djandji; Jacques Bouchard; Eliofotisti Psaradellis; John S Sampalis; R Robert Schellenberg; R Andrew McIvor
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409

7.  Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial).

Authors:  J Mark FitzGerald; Sylvain Foucart; Stephen Coyle; John Sampalis; Denis Haine; Eliofotisti Psaradellis; R Andrew McIvor
Journal:  Can Respir J       Date:  2009 May-Jun       Impact factor: 2.409
  7 in total
  1 in total

1.  Asthma management in the real world: The perils of simplicity.

Authors:  Anthony D D'Urzo
Journal:  Can Fam Physician       Date:  2010-10       Impact factor: 3.275
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.